Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA

Update Il y a 4 ans
Reference: NCT02348619

Woman and Man

Extract

This trial is a 6-week, double-blind, placebo-controlled, randomized-withdrawal, multicenter study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with OSA.


Inclusion criteria

  • Obstructive Sleep Apnea


Links